Stock Price
1.31
Daily Change
0.09 7.38%
Monthly
14.91%
Yearly
-11.49%
Q2 Forecast
1.19

Actinium Pharmaceuticals reported 81K in Gross Profit on Sales for its fiscal quarter ending in December of 2023.





Gross Profit On Sales Change Date
AbbVie USD 12.54B 474M Mar/2026
Actinium Pharmaceuticals 81K 36K Dec/2023
Amgen USD 6.89B 415M Dec/2025
Bioline Rx USD 343K 111K Sep/2025
Capricor Therapeutics 11.13M 8.87M Dec/2024
Pfizer USD 11.04B 1.24B Mar/2026